Android app Apple app link

Enlivex enrols all patients in Phase II stage of knee osteoarthritis trial

By Yahoo! Finance   |   2 weeks ago
Enlivex enrols all patients in Phase II stage of knee osteoarthritis trial

Enlivex Therapeutics has completed Phase II enrollment for its trial of Allocetra in knee osteoarthritis, with 133 subjects randomized. Positive interim results from Phase I guided dosage for Phase II, which includes an independent interim assessment and plans to increase patient cohort.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.